MRK [merck & company ] bullishUS STOCK merk&company is in demand zone .its time to take long
drawn on liquidity = 97 $
target 97 $
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
121.99 MXN
356.88 B MXN
1.33 T MXN
2.50 B
About Merck & Company, Inc.
Sector
Industry
CEO
Robert M. Davis
Website
Headquarters
Rahway
Founded
1891
ISIN
US58933Y1055
FIGI
BBG000HW8MN8
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Related stocks
Merck Significant Upside on the cardsMerck has made a Kiss of Love in True Strength Indicator 1Day Chart. 1Day Fisher Transform has made a Double Bottom. 1W Fisher is already up.
A significant rise is on the cards. It has also come out of TRIANGLE pattern at Bottom.
A Buy at current level.
Target - 1Day Fisher Top (Few weeks).
Merck & Company: Channel Breakout & Target is 0.6 Fib, +13% ROIIn Merck & Company, a Rising Channel Pattern has formed, and the Trendline has Breakout below. The Target is the 0.5 or 0.6 Fibonacci Retracement levels, with the Potential to Achieve a +13% Profit.
MRK Price Action Trading AnalysisConfirmation for this Short Entry:-
1: Market Taking Rejection from Supply Area
2: forming Triangle pattern and Market taking pullback from upper trend line
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
MRK.GF
Merck & Co., Inc. 5.76% 03-MAY-2037Yield to maturity
5.70%
Maturity date
May 3, 2037
MRK.GA
Merck & Co., Inc. 6.3% 01-JAN-2026Yield to maturity
5.60%
Maturity date
Jan 1, 2026
MRK5584756
Merck & Co., Inc. 5.15% 17-MAY-2063Yield to maturity
5.46%
Maturity date
May 17, 2063
MRK5584755
Merck & Co., Inc. 5.0% 17-MAY-2053Yield to maturity
5.41%
Maturity date
May 17, 2053
MRK4806294
Merck & Co., Inc. 4.0% 07-MAR-2049Yield to maturity
5.40%
Maturity date
Mar 7, 2049
MRK6166087
Merck & Co., Inc. 5.7% 15-SEP-2055Yield to maturity
5.38%
Maturity date
Sep 15, 2055
MRK5002693
Merck & Co., Inc. 2.45% 24-JUN-2050Yield to maturity
5.35%
Maturity date
Jun 24, 2050
US58933YBF1
Merck & Co., Inc. 2.75% 10-DEC-2051Yield to maturity
5.35%
Maturity date
Dec 10, 2051
US58933YAT2
Merck & Co., Inc. 3.7% 10-FEB-2045Yield to maturity
5.31%
Maturity date
Feb 10, 2045
MRK5319197
Merck & Co., Inc. 2.9% 10-DEC-2061Yield to maturity
5.29%
Maturity date
Dec 10, 2061
US58933YAJ4
Merck & Co., Inc. 4.15% 18-MAY-2043Yield to maturity
5.25%
Maturity date
May 18, 2043
See all MRK bonds
Curated watchlists where MRK is featured.
Frequently Asked Questions
The current price of MRK is 1,598.33 MXN — it has decreased by −0.43% in the past 24 hours. Watch Merck & Co., Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange Merck & Co., Inc. stocks are traded under the ticker MRK.
MRK stock has fallen by −2.60% compared to the previous week, the month change is a 2.46% rise, over the last year Merck & Co., Inc. has showed a −25.66% decrease.
We've gathered analysts' opinions on Merck & Co., Inc. future price: according to them, MRK price has a max estimate of 2,530.48 MXN and a min estimate of 1,514.59 MXN. Watch MRK chart and read a more detailed Merck & Co., Inc. stock forecast: see what analysts think of Merck & Co., Inc. and suggest that you do with its stocks.
MRK stock is 0.00% volatile and has beta coefficient of 0.54. Track Merck & Co., Inc. stock price on the chart and check out the list of the most volatile stocks — is Merck & Co., Inc. there?
Today Merck & Co., Inc. has the market capitalization of 3.95 T, it has increased by 5.90% over the last week.
Yes, you can track Merck & Co., Inc. financials in yearly and quarterly reports right on TradingView.
Merck & Co., Inc. is going to release the next earnings report on Oct 30, 2025. Keep track of upcoming events with our Earnings Calendar.
MRK earnings for the last quarter are 39.95 MXN per share, whereas the estimation was 38.14 MXN resulting in a 4.77% surprise. The estimated earnings for the next quarter are 43.12 MXN per share. See more details about Merck & Co., Inc. earnings.
Merck & Co., Inc. revenue for the last quarter amounts to 296.49 B MXN, despite the estimated figure of 297.59 B MXN. In the next quarter, revenue is expected to reach 310.87 B MXN.
MRK net income for the last quarter is 83.04 B MXN, while the quarter before that showed 104.05 B MXN of net income which accounts for −20.19% change. Track more Merck & Co., Inc. financial stats to get the full picture.
Yes, MRK dividends are paid quarterly. The last dividend per share was 14.90 MXN. As of today, Dividend Yield (TTM)% is 3.78%. Tracking Merck & Co., Inc. dividends might help you take more informed decisions.
Merck & Co., Inc. dividend yield was 3.14% in 2024, and payout ratio reached 46.32%. The year before the numbers were 2.72% and 2.07 K% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 14, 2025, the company has 75 K employees. See our rating of the largest employees — is Merck & Co., Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Merck & Co., Inc. EBITDA is 502.08 B MXN, and current EBITDA margin is 39.30%. See more stats in Merck & Co., Inc. financial statements.
Like other stocks, MRK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Merck & Co., Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Merck & Co., Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Merck & Co., Inc. stock shows the sell signal. See more of Merck & Co., Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.